Anmelden Kostenlos registrieren

QSAM Biosciences Bruttomarge

Was ist das Bruttomarge von QSAM Biosciences?

Bruttomarge von QSAM Biosciences, Inc. ist 116.73%

Was ist die Definition von Bruttomarge?



Die Bruttomarge ist die Differenz zwischen Umsatz und Kosten der verkauften Waren, dividiert durch den Umsatz und in Prozent ausgedrückt.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Bruttomarge von Unternehmen in Health Care Sektor auf OTC im Vergleich zu QSAM Biosciences

Was macht QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Unternehmen mit bruttomarge ähnlich QSAM Biosciences